Products & Services


HuProt™ microarray-powered biomarker discovery service Read more.


"Pre-treatment IgG autoantibodies associated with favorable Ipilimumab outcomes in melanoma include testis antigens and proteins linked to neurodegeneration" Check it out HERE.

Companion Rapid Communication:  Read it here.


"Predictive Biomarkers of Immunotherapy Toxicity in Metastatic Melanoma Patients" Check it out HERE


HuProt™ v3.1

Using state-of-the-art non-contact piezoelectric printing technology. Now with ~81% of the human proteome. Read more.


ChIP-Seq mMAbs

Monospecific MABs to transcription factors highly suited for ChIP-Seq - and HuProt™ specificity validated. Read more.

Support & Company News

JUST PUBLISHED! (4-2-18)   featuring HuProt™

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
Gowen et al. J Transl Med (2018) 16:82 .
Read it here.

Visit the HuProt web page for more publications.


Latest Press Release 3-28-18

CDI Labs' Monoclonal Antibody Development Pipeline featured in Nature Methods
Proteomics company leverages microarray capability to develop truly monospecific monoclonal antibodies.
Read more.


New Distribution Partner

Arrayjet is now a CDI Laboratories distributor servicing Europe. All distributors.


CDI Interviewed by SCIENCE/AAAS

"Biomarkers on the brain: Putting biomarkers together for a better understanding of the nervous system"
HuProt microarray being adopted for use in biomarker discovery for various neurodegenerative diseases such as multiple sclerosis, neuropsychiatric lupus, Alzheimer’s, and Parkinson’s. Read more.


Latest Press Release 11-28-17

CDI Labs Cites New Research Identifying Early Lung Cancer Autoantibody Biomarkers using HuProt™
Proteomics company's high-content proteome microarray gaining traction in disease diagnosis and prognosis.
Read more.


Press Release 5-25-17

CDI Labs Expands HuProt™ - The Highest Content Human Proteome Microarray in the World
Proteomics company now producing glass slides printed with recombinant human proteins comprising 81% of the human proteome for high throughput analytics, contract research and hybridoma development services. Read more.


Press Release 4-22-17

CDI Laboratories and NeoBiotechnologies Form Alliance
NeoBio to Distribute CDI's 2500 Monospecific Transcription Factor Antibodies. Read more.


CDI CEO Dr. Ignacio Pino Honored

Nine Indian American Scientists Honored by SAASCR for Cancer Research Contributions. Read more.

image description


White Paper

Antibody Cross-Reactivity Testing Using the HuProt™ Human Proteome Microarray
Analysis of several commercially available antibodies against nearly 75% of the human proteome. Read more.


HuProt™ FAQs

A comprehensive collection of topics relating to the handling, content, use and applications of the HuProt Human Proteome Microarray. Read more.


CDI Literature

Downloadable and print-friendly flyers describing products and services. Read more.


Now, a TOLL-FREE phone number for the United States and Canada.

New Distribution Partner

Filgen Inc. is now a CDI Laboratories distributor servicing Japan and South Korea. All distributors.


Red Nose Day

CDI celebrates a special day to come together, have fun and make a difference for kids. Laugh. Give. Save a kid.

image description

Demo Day

CDI Laboratories was invited to - and participated in - the First “Demo Day” Hosted by President Obama at the White House on August 4th. Read more. Press release

image description CDI President and CEO, Dr. Ignacio Pino meets President Obama.